Stephen Brigido

Stephen Brigido

No open positions remaining

Net worth: 17 527 $ as of 31/08/2026

57 year
Consumer Services
Health Technology
Health Services

Profile

Dr. Stephen A. Brigido is a Chief Innovation Officer & Director at Innovative Midfoot Solutions, Inc., a Managing Partner at BBHP Medical LLC, a Director & Partner at Plasmology4, Inc., a Managing Partner at Venel Holdings LLC and a Professor at The Commonwealth Medical College.
He is on the Board of Directors at Innovative Midfoot Solutions, Inc. and Plasmology4, Inc. Dr. Brigido was previously employed as a President-Degenerative Disease by Celularity, Inc. and a President & Chief Medical Officer by Edge Orthopedics LLC.
He also served on the board at Coordinated Health Holding Co. LLC.
He received his undergraduate degree from Randolph-Macon College and a doctorate degree from Temple University (Pennsylvania).

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
13/04/2026 9,474 ( 0.04% ) 17 527 $ 31/08/2026

Stephen Brigido active positions

CompaniesPositionStart
Director/Board Member 01/01/2012
Corporate Officer/Principal -
BBHP Medical LLC
Corporate Officer/Principal 01/10/2016
Venel Holdings LLC
Corporate Officer/Principal 01/11/2010

Former positions of Stephen Brigido

CompaniesPositionEnd
CELULARITY INC. Corporate Officer/Principal 15/04/2026
Director/Board Member 01/01/2019
President 01/07/2016
See the detail of Stephen Brigido's experience

Training of Stephen Brigido

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

42

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Services

Commercial Services

BBHP Medical LLC

Venel Holdings LLC

Distribution Services

  1. Stock Market
  2. Insiders
  3. Stephen Brigido
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!